This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS Slashes Generic Drug Prices

OKLAHOMA CITY -- CVS-Caremark (CVS - Get Report) is introducing next month a "health savings pass" that promises cut-rate prices on hundreds of generic drugs used to treat common conditions such as diabetes and high blood pressure.

After purchasing the $10 pass, CVS customers will pay just $9.99 -- a penny less than they would at Wal-Mart (WMT - Get Report) -- for a 90-day supply of 400 different generic maintenance drugs.

With that same card, cash-paying customers can also receive a 10% discount for treatment provided by the company's in-store MinuteClinics.

"People are struggling with health care costs, especially the uninsured and the underinsured," CVS CEO Tom Ryan stated when introducing the new program on Thursday. "As the largest provider of pharmacy health care in the nation, we felt it was the right time to offer consumers another way to make their health care more affordable.

"This new program will not only provide affordability and convenience," Ryan continued, "but also the superior service and execution that consumers have come to expect from CVS."

CVS could pay a price, however. While the new savings program might attract more shoppers to its stores -- including some who now buy cheap generics at Wal-Mart or Target (TGT) -- it will threaten a key source of profits in the process.

Right now, CVS can often make more money marking up a cheap generic drug than it can by selling its expensive brand-name counterpart. For the drugs covered under its new savings card, however, that dependable margin-booster will shrink or disappear.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WMT $66.84 -0.53%
WAG $81.65 2.05%
MHS $70.30 0.00%
CVS $105.38 1.40%
ESRX $73.19 0.62%


Chart of I:DJI
DOW 17,692.42 +41.16 0.23%
S&P 500 2,054.58 +3.46 0.17%
NASDAQ 4,733.4520 +7.8130 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs